Results 181 to 190 of about 39,021 (326)
SY18-3 Current status and future perspectives of ctDNA in head and neck cancer [PDF]
T. Enokida
openalex +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 403-413, February 2026.Circulating tumor cells (CTCs) and tumor‐derived extracellular vesicles (tdEVs) are promising biomarkers for predicting survival and informing treatment decisions in metastatic colorectal cancer (mCRC); yet their clinical application remains limited. In this study, we analyzed CellSearch image archives from 446 patients with mCRC treated in the CAIRO2 ...
Maddalena Centanni +6 more
wiley +1 more source
Head &Neck, Volume 48, Issue 2, Page 543-548, February 2026.ABSTRACT Background Cystic lateral neck masses in adults commonly represent nodal metastases from HPV‐associated oropharyngeal squamous cell carcinoma (OPSCC) or benign lesions. Because cystic lesions are relatively acellular, fine‐needle aspiration (FNA) is often non‐diagnostic.
Michael R. Papazian +4 more
wiley +1 more source
International Journal of Cancer, Volume 158, Issue 3, Page 511-526, 1 February 2026.Abstract Viral infections play a significant role in cancer development, making detecting viral signatures a promising approach for early cancer diagnosis. Circulating free DNA (cfDNA), released into the bloodstream by tumors and other cells, has emerged as a powerful biomarker for non‐invasive cancer screening.
Richard Donkor Amponsah +4 more
wiley +1 more source
International Journal of Cancer, Volume 158, Issue 3, Page 790-798, 1 February 2026.What's new? Chemoradiotherapy is the standard treatment for squamous cell carcinoma of the anus (SCCA). Toxicities linked to chemoradiotherapy, however, can negatively impact the quality of life, and biomarkers to distinguish which patients will benefit from treatment are lacking.
Anne Vittrup Jakobsen +4 more
wiley +1 more source
Supplementary Figure 8 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer [PDF]
Gillian Vandekerkhove +32 more
openalex +1 more source
Radiogenomics: Current Understandings and Future Perspectives
MedComm, Volume 7, Issue 2, February 2026.Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang +8 more
wiley +1 more source
Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. [PDF]
PLoS OnePark Y +8 more
europepmc +1 more source
Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
The Prostate, Volume 86, Issue 3, Page 338-348, February 15, 2026.ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez +8 more
wiley +1 more source